FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2606572014> ?p ?o ?g. }

• W2606572014 endingPage "585" @default.
• W2606572014 startingPage "575" @default.
• W2606572014 abstract "Endometriosis is a gynaecological disease that is characterised by the presence of endometrium like tissue-epithelium and stroma that develops outside the uterine cavity, which is responsible for pelvic pain and infertility. Even though several medical therapies exist for the treatment of endometriosis, each of the drug class has its own limitations such as cost of treatment, side-effects and its short-term effect on the symptoms of endometriosis. In this review, we have attempted to summarize the current status and challenges of drug development for endometriosis.A systematic review was done and all the RCTs were selected from the identified hits. We included studies that explored the usage of therapeutic drugs on endometriosis patients from inception till November 2016. The search term used was 'Endometriosis' using PubMed and Clinicaltrials.gov. For the final analysis, 60 articles were analyzed and we identified the newly emerging drug therapies for endometriosis treatment and have briefed their current status and challenges in drug development for endometriosis. The quality of the selected studies was assessed based on the degree of bias.The current classes of drugs that have shown promising therapeutic results include Gonadotropin- releasing hormone (GnRH) antagonists, aromatase inhibitors (AI), and selective progesterone and estrogen receptor modulators, dopamine receptor-2-agonists and statins. The drugs that failed midway during development include tanezumab, rosiglitazone, infliximab, pentoxifylline, telapristone acetate, asoprisnil and raloxifene.From the literature review, it appears that the most promising molecules for the treatment of endometriosis in the near future include elagolix, mifepristone, TAK-385, KLH-2109 and ASP1707 and cabergoline. It remains to be seen if these molecules would succeed large phase 3 clinical trials and overcome the regulatory hurdles to become an essential tool in the gynaecologist's armamentarium against endometriosis." @default.
• W2606572014 created "2017-04-28" @default.
• W2606572014 creator A5024252441 @default.
• W2606572014 creator A5031940496 @default.
• W2606572014 creator A5052353127 @default.
• W2606572014 date "2017-06-01" @default.
• W2606572014 modified "2023-10-16" @default.
• W2606572014 title "A peek into the drug development scenario of endometriosis – A systematic review" @default.
• W2606572014 cites W1964923339 @default.
• W2606572014 cites W1966028477 @default.
• W2606572014 cites W1966866942 @default.
• W2606572014 cites W1972005184 @default.
• W2606572014 cites W1974271050 @default.
• W2606572014 cites W1975201860 @default.
• W2606572014 cites W1975317736 @default.
• W2606572014 cites W1986914259 @default.
• W2606572014 cites W1987941106 @default.
• W2606572014 cites W2003063828 @default.
• W2606572014 cites W2004563010 @default.
• W2606572014 cites W2008758386 @default.
• W2606572014 cites W2011872572 @default.
• W2606572014 cites W2015536508 @default.
• W2606572014 cites W2015901402 @default.
• W2606572014 cites W2027475010 @default.
• W2606572014 cites W2032337615 @default.
• W2606572014 cites W2040325288 @default.
• W2606572014 cites W2045267136 @default.
• W2606572014 cites W2052516455 @default.
• W2606572014 cites W2062637361 @default.
• W2606572014 cites W2067202752 @default.
• W2606572014 cites W2068165479 @default.
• W2606572014 cites W2071333951 @default.
• W2606572014 cites W2078447913 @default.
• W2606572014 cites W2079070934 @default.
• W2606572014 cites W2083701448 @default.
• W2606572014 cites W2085320423 @default.
• W2606572014 cites W2088302318 @default.
• W2606572014 cites W2090986875 @default.
• W2606572014 cites W2092177969 @default.
• W2606572014 cites W2094952516 @default.
• W2606572014 cites W2096980318 @default.
• W2606572014 cites W2098269857 @default.
• W2606572014 cites W2101288911 @default.
• W2606572014 cites W2101417341 @default.
• W2606572014 cites W2101934635 @default.
• W2606572014 cites W2105478806 @default.
• W2606572014 cites W2113505635 @default.
• W2606572014 cites W2116209432 @default.
• W2606572014 cites W2117630250 @default.
• W2606572014 cites W2118269130 @default.
• W2606572014 cites W2129779878 @default.
• W2606572014 cites W2131145289 @default.
• W2606572014 cites W2131750491 @default.
• W2606572014 cites W2132577372 @default.
• W2606572014 cites W2135754669 @default.
• W2606572014 cites W2138336325 @default.
• W2606572014 cites W2142774140 @default.
• W2606572014 cites W2147700987 @default.
• W2606572014 cites W2148368274 @default.
• W2606572014 cites W2149342667 @default.
• W2606572014 cites W2151447010 @default.
• W2606572014 cites W2152982261 @default.
• W2606572014 cites W2157853773 @default.
• W2606572014 cites W2158134092 @default.
• W2606572014 cites W2159803441 @default.
• W2606572014 cites W2167064297 @default.
• W2606572014 cites W2169590550 @default.
• W2606572014 cites W2177311010 @default.
• W2606572014 cites W2178349541 @default.
• W2606572014 cites W2239033986 @default.
• W2606572014 cites W2337137963 @default.
• W2606572014 cites W2341654050 @default.
• W2606572014 cites W2399797665 @default.
• W2606572014 cites W2522528813 @default.
• W2606572014 cites W2593412351 @default.
• W2606572014 doi "https://doi.org/10.1016/j.biopha.2017.03.092" @default.
• W2606572014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28407578" @default.
• W2606572014 hasPublicationYear "2017" @default.
• W2606572014 type Work @default.
• W2606572014 sameAs 2606572014 @default.
• W2606572014 citedByCount "27" @default.
• W2606572014 countsByYear W26065720142017 @default.
• W2606572014 countsByYear W26065720142018 @default.
• W2606572014 countsByYear W26065720142019 @default.
• W2606572014 countsByYear W26065720142020 @default.
• W2606572014 countsByYear W26065720142021 @default.
• W2606572014 countsByYear W26065720142022 @default.
• W2606572014 countsByYear W26065720142023 @default.
• W2606572014 crossrefType "journal-article" @default.
• W2606572014 hasAuthorship W2606572014A5024252441 @default.
• W2606572014 hasAuthorship W2606572014A5031940496 @default.
• W2606572014 hasAuthorship W2606572014A5052353127 @default.
• W2606572014 hasConcept C121608353 @default.
• W2606572014 hasConcept C126322002 @default.
• W2606572014 hasConcept C143998085 @default.
• W2606572014 hasConcept C2776166826 @default.
• W2606572014 hasConcept C2777176818 @default.
• W2606572014 hasConcept C2777688143 @default.

• next